dermatomyositis: Dermatomyositis (DM) is a type of idiopathic inflammatory myopathy characterized by evocative skin lesions and symmetrical proximal muscle weakness.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
181 |
4. Check minimum number of eventsNone |
181 |
5. Include endpointsNone |
181 |
6. Filter based on genotype QC (FinnGen only) |
181 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M33
- Name in latin
- Dermato[poly]myositis non specificata
Similar endpoints
↥List of similar endpoints to
Dermatopolymyositis, unspecified
based on the number of shared cases.
Similar with more cases:
- Dermatopolymyositis (FG)
- Dermatopolymyositis
- Systemic connective tissue disorders
- Autoimmune diseases related-to ILD
- Finngen Rheumatological endpoints
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 919 | 568 | 346 |
| Only index persons | 811 | 503 | 308 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.02 | 0.01 |
| Only index persons | 0.02 | 0.02 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 59.15 | 58.28 | 60.73 |
| Only index persons | 57.73 | 56.78 | 59.29 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 181 | 105 | 76 |
| Unadjusted period prevalence (%) | 0.03 | 0.04 | 0.03 |
| Median age at first event (years) | 56.65 | 52.96 | 61.74 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 170
- Matched controls
- 1697
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M33.9
ICD-10 Finland
Dermatopolymyositis, unspecified
+∞
239.7
168
*
M33.1
ICD-10 Finland
Other dermatomyositis
+∞
74.6
66
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
22.4
60.3
97
95
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
11.1
44.6
121
309
M33.2
ICD-10 Finland
Polymyositis
+∞
43.6
40
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
14.3
41.0
77
93
H02AB06
ATC
prednisolone; systemic
11.5
40.2
144
551
L04AX01
ATC
azathioprine; systemic
36.7
39.2
50
19
P01BA02
ATC
hydroxychloroquine; oral
16.0
37.6
65
63
M60.9
ICD-10 Finland
Myositis, unspecified
378.8
32.0
31
*
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
+∞
29.0
27
*
M05BA04
ATC
alendronic acid; oral
14.1
27.1
48
46
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
13.1
25.7
47
48
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
+∞
25.7
24
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
12.4
25.5
48
52
G72.9
ICD-10 Finland
Myopathy, unspecified
97.2
23.4
25
*
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
251.0
22.1
22
*
NXL00
NOMESCO Finland
Biopsy of muscle
+∞
21.3
20
*
L04AA06
ATC
mycophenolic acid; systemic
48.5
21.1
25
6
J99.1*M33.9
ICD-10 Finland
Respiratory disorders in dermatopolymyositis
+∞
20.2
19
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
13.1
19.6
35
33
M60.8
ICD-10 Finland
Other myositis
+∞
17.0
16
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
6.3
14.6
41
81
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
14.2
104
519
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
+∞
12.7
12
*
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
6.6
12.5
33
60
L04AD01
ATC
ciclosporin; systemic
19.9
12.3
18
10
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
+∞
11.6
11
*
M05BA07
ATC
risedronic acid; oral
18.7
11.5
17
10
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.2
11.0
73
320
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
12.4
10.9
19
17
XA402
NOMESCO Finland
ENMG
17.5
10.6
16
10
M33.0
ICD-10 Finland
Juvenile dermatomyositis
+∞
10.5
10
*
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
+∞
10.5
10
*
J99.1*M33.2
ICD-10 Finland
Respiratory disorders in polymyositis
+∞
10.5
10
*
M35.1
ICD-10 Finland
Other overlap syndromes
+∞
10.5
10
*
H02AB07
ATC
prednisone; oral
4.1
10.2
43
130
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
15.9
10.2
16
11
L04AA01
ATC
[U] ciclosporin; systemic
21.6
10.0
14
7
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
7.7
9.7
22
32
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.2
9.1
55
218
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
9.1
38
114
A02BC02
ATC
pantoprazole; systemic
2.9
9.0
125
838
ZX120
NOMESCO Finland
Intravenous
4.5
8.8
32
84
M33
ICD-10 Finland
Dermatopolymyositis
+∞
8.4
8
*
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
+∞
8.4
8
*
JN4BD
NOMESCO Finland
Extensive body CT
4.1
8.3
33
94
XG410
NOMESCO Finland
Flow-volume spirometry
6.3
8.1
21
37
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
6.5
8.0
20
34
R50.9
ICD-10 Finland
Fever, unspecified
3.6
7.7
36
118
R13
ICD-10 Finland
Dysphagia
5.8
7.7
21
40
1XC02
NOMESCO Finland
NA
83.6
7.5
8
*
D07AB08
ATC
desonide; topical
3.6
7.2
33
107
M05BB03
ATC
alendronic acid and colecalciferol; oral
17.6
6.8
10
6
D07AC01
ATC
betamethasone; topical
2.5
6.8
71
384
M79.0
ICD-10 Finland
Rheumatism, unspecified
9.3
6.7
13
15
L99
ICPC
Musculoskeletal disease other
13.0
6.7
11
9
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
13.0
6.7
11
9
R06.0
ICD-10 Finland
Dyspnoea
2.6
6.6
55
263
N03AX16
ATC
pregabalin; oral
2.7
6.5
48
213
E0000UV
ATC
NA
2.3
6.5
76
435
L88
ICPC
Rheumatoid/seropositive arthritis
6.4
6.5
16
27
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.6
6.4
29
93
NJ3DG
NOMESCO Finland
Very extensive MRI examination of extremities with high intensity magnet
+∞
6.3
6
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
6.1
44
193
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
7.7
6.0
13
18
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
64
6
163.27
63.78
4.0
1.3
u/l
6.6
5.5
—
59
6
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
58
5
169.02
57.80
1.4
1.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
145
434
12.77
55.30
13.5
1.9
u/l
196.8
183.7
0.16
145
406
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
50
38
17.80
55.10
2.6
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
93
176
9.81
53.58
2.1
1.3
titre
638.0
425.7
1.26
41
42
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
45
40
14.64
44.92
1.9
1.1
g/l
0.2
0.3
1.86
45
40
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
45
43
13.60
42.86
1.9
1.0
g/l
1.1
1.3
2.33
45
43
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
35
38
11.18
30.17
1.7
1.4
iu/ml
366.8
0.1
—
9
8
(3001604) Monocytes [#/volume] in Blood
149
733
6.84
26.09
16.6
5.4
e9/l
0.6
0.6
0.53
143
640
(3006315) Basophils [#/volume] in Blood
149
734
6.83
26.02
16.7
5.4
e9/l
0.0
0.0
0.98
143
643
(42870588) Differential panel, method unspecified - Blood
116
468
5.12
25.93
14.8
5.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
52
121
5.63
22.38
8.8
4.6
%
0.9
0.9
0.02
21
41
(3021440) Promyelocytes/100 leukocytes in Blood
49
112
5.63
21.45
9.2
4.8
%
0.2
0.2
0.12
20
38
(3025159) Blasts/100 leukocytes in Blood
48
108
5.69
21.37
9.0
4.7
%
0.0
0.0
0.49
18
33
(3002179) Metamyelocytes/100 leukocytes in Blood
47
110
5.42
19.94
7.9
4.7
%
0.9
0.4
0.61
17
30
(3013650) Neutrophils [#/volume] in Blood by Automated count
152
870
5.66
19.20
19.5
9.6
e9/l
4.2
4.0
0.66
147
763
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
16
10
17.45
18.73
1.6
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
16
10
17.45
18.73
1.6
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
16
10
17.45
18.73
1.6
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
16
11
15.86
17.84
1.6
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
16
11
15.86
17.84
1.6
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
16
11
15.86
17.84
1.6
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
77
308
3.61
15.59
2.3
1.4
g/l
2.2
2.4
0.39
65
179
(3004616) Nuclear Ab [Presence] in Serum
18
19
10.41
15.48
1.9
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
60
205
3.88
15.35
1.5
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
53
173
3.92
14.39
1.6
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
18
21
9.41
14.38
4.6
2.7
%
61.6
64.0
0.25
18
21
(3004588) Protein electrophoresis panel - Serum or Plasma
35
85
4.87
13.96
4.6
3.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
17
20
9.28
13.47
4.3
1.8
e9/l
4.4
6.0
1.07
17
20
(3035350) Ketones [Presence] in Urine by Test strip
122
714
3.17
12.18
5.2
3.4
estimate
0.0
0.0
0.00
34
137
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
13
12
11.59
12.09
1.5
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
123
733
3.12
11.70
5.3
3.3
estimate
0.0
0.0
0.00
34
134
(3021879) Hepatitis B virus core Ab [Presence] in Serum
37
108
4.05
11.58
1.2
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
121
725
3.02
11.21
6.5
4.4
estimate
0.0
0.0
0.00
34
140
(3021788) Differential panel - Synovial fluid
15
19
8.52
11.18
1.5
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
28
68
4.69
11.08
1.1
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
106
601
2.84
10.73
3.5
2.2
nmol/l
73.0
77.0
0.81
101
537
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
120
727
2.93
10.69
10.2
6.4
mmol/l
1.2
1.2
0.48
103
621
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
49
185
3.26
10.36
3.0
2.1
%
24.8
23.6
0.20
44
165
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
22
46
5.31
10.31
4.3
2.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
39
128
3.61
10.26
1.8
1.9
nmol/l
406.8
362.4
0.18
39
117
(3037467) Urinalysis macro (dipstick) panel - Urine
147
1010
3.42
10.18
9.0
3.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
15
23
7.02
9.51
8.7
8.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
11
12
9.70
9.07
2.5
4.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
49
201
2.97
8.88
3.1
2.0
g/l
2.3
2.3
0.41
49
182
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
19
40
5.19
8.81
1.7
1.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
10
10
10.53
8.72
1.6
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
16
29
5.96
8.66
1.6
2.0
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
20
45
4.87
8.60
6.2
2.8
g/l
36.9
38.3
0.36
20
40
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
19
41
5.06
8.57
6.5
3.0
g/l
0.0
0.0
0.00
19
41
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
11
13
8.94
8.55
1.4
1.2
%
8.8
64.8
—
5
8
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
50
213
2.86
8.42
2.3
1.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
69
347
2.60
8.40
3.1
1.8
mg/l
3.3
3.0
0.55
63
300
(3021589) Normoblasts [#/volume] in Blood
107
663
2.50
8.29
20.2
9.1
e9/l
0.0
0.0
0.26
98
538
(40760892) CBC W Ordered Manual Differential panel - Blood
65
321
2.60
8.18
11.7
4.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
81
446
2.48
8.07
6.1
3.9
ph
7.4
7.4
0.47
20
77
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
18
39
5.01
8.07
6.8
3.1
g/l
0.0
0.0
0.00
18
39
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
18
39
5.01
8.07
6.8
3.1
g/l
0.0
0.0
0.00
18
39
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
55
252
2.70
8.02
1.5
1.2
iu/ml
70.5
35.8
0.60
14
82
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
51
4.28
7.38
6.3
2.6
g/l
3.1
2.9
0.27
20
44
(4035726)
37
146
2.93
7.08
1.1
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
15
31
5.19
7.07
1.3
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
15
31
5.19
7.07
1.7
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
75
419
2.35
7.03
5.8
3.0
ng/l
866.9
1052.0
0.44
70
353
(3023368) Bacteria identified in Blood by Culture
69
373
2.37
6.96
6.1
4.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
26
84
3.45
6.91
3.2
3.3
kpa
4.9
5.1
0.89
26
77
(3000494) Fungus identified in Specimen by Culture
42
180
2.74
6.89
1.9
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
71
393
2.33
6.75
6.3
3.8
estimate
0.0
0.0
0.00
34
135
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
55
3.96
6.68
6.3
2.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
55
3.96
6.68
6.3
2.5
g/l
3.5
3.6
0.21
20
43
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
55
3.96
6.68
6.3
2.5
g/l
7.1
7.3
0.20
20
45
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
5
18.83
6.33
1.8
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
13
26
5.31
6.33
1.2
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
86
542
2.12
5.73
4.5
3.3
e6/l
59.5
70.6
0.09
62
378
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
11
21
5.51
5.60
1.2
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
34
145
2.66
5.57
1.9
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
69
403
2.15
5.57
4.7
2.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
20
63
3.44
5.51
3.5
3.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
26
4.87
5.34
1.7
1.7
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
12
26
4.87
5.34
1.2
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
35
4.25
5.27
1.6
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
29
118
2.74
5.19
2.3
2.5
e9/l
84.2
70.5
0.98
24
94
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
19
5.51
5.10
1.5
1.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
18
56
3.46
5.04
1.6
1.6
g/l
1.2
1.6
1.94
18
48
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
47
244
2.25
5.01
1.2
1.2
u/ml
37.7
9.0
0.62
14
90
(3017817) Protein [Mass] in Urine collected for unspecified duration
8
7
11.88
4.83
1.6
5.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
82
536
1.97
4.70
4.5
2.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
85
563
1.96
4.69
5.8
3.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
58
337
2.06
4.61
1.4
1.2
u/ml
0.8
1.6
0.68
13
92
(3011397) Hemoglobin [Presence] in Urine by Test strip
57
331
2.05
4.53
4.9
3.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
40
3.71
4.43
1.2
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
32
148
2.41
4.41
2.1
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
22
4.75
4.36
1.5
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
22
4.75
4.36
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
13
36
3.81
4.29
1.7
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
66
411
1.95
4.28
13.8
6.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
20
74
2.91
4.25
1.7
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
46
252
2.11
4.24
2.0
1.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
48
269
2.07
4.16
1.9
1.6
nmol/l
1174.5
1190.0
0.04
40
205
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
10
23
4.54
4.14
1.1
1.3
u/ml
3.4
15.4
—
5
5
(1761868) Lipid panel - Serum or Plasma
29
547
0.44
4.07
3.1
2.8
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
9
14
6.70
4.03
2.0
1.4
mg/l
2.6
4.1
—
9
14
(4062490)
9
14
6.70
4.03
1.2
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
24
4.35
3.94
1.2
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
24
4.35
3.94
1.2
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
29
3.97
3.86
1.5
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
61
383
1.89
3.79
4.2
2.8
umol/l
6763.7
9651.0
0.16
55
332
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
5
12.34
3.79
1.8
2.8
u/ml
870.8
1242.0
—
6
5
(3002582) Erythrocytes [#/volume] in Urine
71
470
1.84
3.73
3.8
2.9
e6/l
188.4
37.6
0.40
59
350
(3019060) Gas panel - Arterial blood
21
86
2.63
3.71
3.0
4.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
25
112
2.43
3.68
1.4
1.2
—
38.2
—
0
9
(3044927) Protein electrophoresis panel - Urine
7
9
8.03
3.59
1.3
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
17
5.51
3.56
1.8
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
64
416
1.83
3.53
3.9
2.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
17
64
2.83
3.51
1.6
1.9
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
24
109
2.39
3.43
4.1
4.4
mmol/l
1.2
1.2
0.10
24
97
(3021960) Folate [Moles/volume] in Serum or Plasma
56
352
1.86
3.42
1.8
1.4
nmol/l
17.8
21.8
1.74
48
298
(40768797) Stomach Pathology biopsy report
35
187
2.08
3.41
1.4
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
27
3.86
3.40
5.7
2.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
65
429
1.80
3.39
4.0
2.8
e6/l
0.2
0.4
1.57
53
313
(3047189) Immunofixation for 24 hour Urine
6
7
8.81
3.28
3.0
2.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
73
505
1.75
3.21
2.4
3.4
mmol/l
2.3
2.4
1.58
67
440
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
43
253
1.92
3.20
3.5
2.6
e6/l
0.8
1.0
0.37
28
137
(3019225) pH of Specimen
28
142
2.15
3.11
8.9
4.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
12
6.02
3.05
1.1
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
17
4.87
2.95
5.5
3.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
9
22
4.25
2.92
3.8
4.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
81
589
1.68
2.91
10.0
7.4
inr
1.2
1.2
0.01
26
170
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
13
5.55
2.89
2.0
1.6
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
7
13
5.55
2.89
1.0
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
23
4.06
2.81
1.9
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
20
92
2.32
2.79
5.0
1.9
e9/l
3.0
3.8
1.05
14
74
(3003396) Base excess in Arterial blood by calculation
29
156
2.02
2.77
6.5
7.3
mmol/l
0.5
1.5
1.09
23
122
(40761535) Cells panel - Urine sediment
23
113
2.19
2.76
4.9
3.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
67
469
1.68
2.75
2.9
2.2
u/l
55.1
55.8
0.07
62
433
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
10
6.16
2.72
1.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
19
4.35
2.71
1.0
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
7
7.30
2.56
1.4
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
7
7.30
2.56
1.4
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
26
3.59
2.52
1.7
1.8
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
24
125
2.06
2.50
7.4
6.7
mmol/l
1.3
1.4
0.16
24
120
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
78
579
1.61
2.49
5.9
3.5
ng/l
81.7
38.7
0.70
72
389
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
38
235
1.78
2.39
3.8
2.8
e6/l
5.6
2.0
1.06
23
121
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
8
6.39
2.38
1.0
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
8
6.39
2.38
2.2
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
13
4.73
2.29
1.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
13
4.73
2.29
1.0
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
18
4.00
2.27
2.4
2.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
11
42
2.72
2.23
1.2
1.2
—
—
—
0
0
(4268621)
7
19
3.79
2.17
1.7
2.2
—
—
—
0
0
(44790049)
6
14
4.39
2.17
1.8
1.5
—
—
—
0
0
(44806118)
6
14
4.39
2.17
1.8
1.5
—
—
—
0
0
(44790047)
6
14
4.39
2.17
1.8
1.5
—
—
—
0
0
(44790048)
6
14
4.39
2.17
1.8
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
14
4.39
2.17
1.2
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
37
234
1.73
2.16
2.4
1.8
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
10
5.11
2.08
1.8
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
20
3.60
2.07
1.6
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
20
3.60
2.07
1.7
3.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
15
4.10
2.05
2.2
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
23
127
1.93
2.05
5.6
3.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
133
1480
0.62
2.04
5.2
4.4
mmol/l
5.7
6.0
2.00
126
1356
(3013290) Carbon dioxide [Partial pressure] in Blood
9
32
2.90
2.03
10.4
3.1
kpa
5.3
5.0
—
9
32
(3027315) Oxygen [Partial pressure] in Blood
9
32
2.90
2.03
10.4
3.1
kpa
8.1
8.6
—
9
32
(3020891) Body temperature
12
51
2.45
1.99
5.6
4.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
18
92
2.06
1.98
1.6
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
11
4.64
1.95
1.0
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
16
3.84
1.95
1.5
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
16
3.84
1.95
1.3
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
57
413
1.55
1.94
3.5
3.1
mg/l
32.1
56.3
0.89
40
260
(3000991) Gas panel - Venous blood
21
117
1.90
1.83
9.6
8.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
21
117
1.90
1.83
1.2
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
125
1401
0.65
1.83
28.7
14.0
%
38.9
40.1
0.78
87
1045
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
47
2.43
1.81
1.2
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
74
2.12
1.81
1.7
2.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
146
0.39
1.74
1.2
1.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
13
3.92
1.72
1.2
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
55
2.27
1.71
3.1
2.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
44
311
1.55
1.65
6.5
3.7
kg/l
1.0
1.0
—
6
42
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
14
3.64
1.62
1.4
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
8
32
2.57
1.61
2.5
2.2
mmol/l
25.7
26.3
—
8
25
(3022145) Colonoscopy Study observation
29
186
1.67
1.61
1.4
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
20
3.07
1.59
1.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
20
3.07
1.59
1.3
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
33
2.49
1.55
1.5
1.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
56
422
1.47
1.55
2.8
2.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
42
0.00
1.55
0.0
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
14
72
2.02
1.53
1.6
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
15
3.40
1.53
1.4
2.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
15
3.40
1.53
1.4
2.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
15
3.40
1.53
1.4
2.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
27
2.65
1.53
2.6
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
21
2.92
1.52
1.3
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
26
166
1.66
1.47
2.6
4.8
ug/l
2.9
33.6
0.66
21
141
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
23
2.66
1.38
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
23
2.66
1.38
1.3
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
5
17
2.99
1.37
1.0
1.1
—
3.9
—
0
6
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
23
147
1.65
1.31
3.4
3.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
48
2.15
1.30
2.9
1.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
57
445
1.41
1.29
3.4
2.9
mmol/l
7.5
7.7
0.12
49
372
(3022806) Fractional oxyhemoglobin in Capillary blood
5
19
2.68
1.22
1.8
2.1
%
89.0
89.4
—
5
19
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
38
278
1.46
1.21
5.8
3.5
ng/l
335.7
292.9
0.08
29
217
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
141
1514
0.69
1.21
5.0
4.5
mmol/l
4.9
4.7
1.16
134
1399
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
140
1505
0.69
1.20
5.0
4.4
mmol/l
1.4
1.5
1.20
132
1386
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
26
2.35
1.19
2.0
2.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
25
168
1.57
1.17
1.6
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
34
0.00
1.17
0.0
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
135
1458
0.71
1.16
4.7
4.0
mmol/l
1.6
1.3
2.81
127
1340
(3018677) aPTT in Platelet poor plasma by Coagulation assay
33
237
1.48
1.15
2.7
1.9
s
29.5
29.1
0.10
33
231
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
30
2.39
1.13
1.9
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
14
81
1.79
1.12
1.2
1.2
u/ml
218.4
149.2
0.15
14
76
(4306422)
5
21
2.42
1.10
1.2
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
33
240
1.46
1.09
1.3
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
128
1158
1.36
1.07
5.2
3.9
pmol/l
15.0
14.7
0.59
122
1041
(3045142) Bone marrow Pathology biopsy report
5
22
2.31
1.04
1.4
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
35
2.04
1.01
1.1
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
72
604
1.32
1.01
2.8
1.9
pmol/l
95.3
95.0
0.02
43
306
(3008037) Lactate [Moles/volume] in Venous blood
0
29
0.00
0.98
0.0
3.2
—
1.7
—
0
29
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
37
1.93
0.95
1.1
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
161
1524
1.51
0.94
33.2
13.0
mg/l
17.7
22.9
1.93
148
1184
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
27
2.26
0.94
1.2
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
146
1545
0.72
0.94
5.3
5.0
mmol/l
2.9
2.8
1.09
138
1426
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
37
284
1.38
0.92
2.1
3.0
mmol/l
2.5
2.5
0.71
32
249
(3022621) pH of Urine by Test strip
16
103
1.61
0.91
3.9
2.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
14
87
1.66
0.90
15.6
5.9
mmol/l
25.9
24.9
0.54
14
87
(3020682) Albumin/Creatinine [Ratio] in Urine
54
441
1.32
0.90
4.3
3.8
mg/mmol
3.3
9.5
2.34
36
271
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
72
1.71
0.87
13.2
8.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
44
1.86
0.87
1.1
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
74
634
1.28
0.86
2.1
2.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
45
1.81
0.85
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
45
1.81
0.85
1.1
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
32
1.90
0.82
1.0
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
42
337
1.32
0.79
2.1
1.7
mg/l
1.4
1.2
0.22
29
266
(3038515) Glucose [Moles/volume] in Venous blood
0
26
0.00
0.79
0.0
3.5
—
8.0
—
0
26
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
14
91
1.58
0.78
1.4
1.2
iu/ml
113.7
124.5
—
5
41
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
38
1.88
0.74
1.0
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
56
1.64
0.73
1.7
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
81
717
1.23
0.69
5.4
4.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
29
1.74
0.64
1.2
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
49
1.66
0.63
2.4
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
137
1443
0.79
0.62
7.1
5.5
mmol/mol
40.6
39.9
0.43
132
1345
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
35
1.74
0.58
3.2
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
8
54
1.50
0.58
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
86
0.57
0.58
1.4
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
39
1.56
0.53
1.2
1.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
12
83
1.48
0.53
11.4
9.7
%
92.0
94.2
0.61
12
83
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
33
395
0.80
0.52
3.7
4.6
%
22.2
21.3
0.16
17
206
(21494755) Public health laboratory ask at order entry panel
10
144
0.68
0.51
1.4
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
12
84
1.46
0.50
1.3
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
57
501
1.20
0.50
2.9
2.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
16
119
1.38
0.50
2.0
1.6
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
5
31
1.63
0.43
2.0
2.1
kpa
9.4
8.1
—
5
26
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
1.0
—
0
7
(3041354) Potassium [Moles/volume] in Venous blood
0
16
0.00
0.41
0.0
3.0
—
4.1
—
0
16
(3035285) Chloride [Moles/volume] in Venous blood
0
16
0.00
0.41
0.0
3.0
—
106.2
—
0
16
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
16
0.00
0.41
0.0
3.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
151
1457
1.22
0.41
25.3
12.5
ml/min/173m2
84.3
81.7
0.60
134
1189
(3000492) Spirometry study
18
142
1.30
0.40
1.9
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
43
376
1.19
0.40
2.7
2.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
18
0.00
0.40
0.0
2.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
22
179
1.26
0.39
1.5
1.9
%
1.8
1.4
1.96
15
158
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
9
69
1.32
0.38
1.4
3.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
24
201
1.22
0.34
5.9
4.4
%
31.8
30.9
0.17
19
125
(3003327) Ova and parasites identified in Stool by Light microscopy
6
45
1.34
0.34
1.3
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
6
45
1.34
0.34
1.0
1.3
—
344.8
—
0
25
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
90
957
0.88
0.33
2.9
2.9
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
16
128
1.27
0.33
4.5
3.7
kpa
6.0
5.8
0.48
16
122
(4034850)
7
53
1.33
0.31
13.6
7.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
158
1614
0.83
0.29
23.8
12.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
76
1.33
0.28
1.2
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
26
299
0.85
0.28
2.8
3.0
ug/l
0.7
0.8
0.37
17
205
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
8
65
1.24
0.27
6.1
3.6
%
56.5
46.8
—
8
65
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
9
73
1.24
0.26
3.7
2.3
%
1.8
1.2
—
9
73
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
145
1410
1.14
0.26
6.0
4.6
mu/l
2.0
1.9
0.62
137
1279
(3025941) Bacteria identified in Stool by Culture
9
74
1.23
0.25
1.2
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
12
146
0.81
0.23
3.6
1.8
—
—
—
0
0
(3013512) EKG study
49
453
1.11
0.22
4.6
3.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
3.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
3.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
11
0.00
0.21
0.0
2.3
—
13.5
—
0
11
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
9.5
—
0.7
—
0
10
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
5
43
1.17
0.21
1.6
4.1
mmol/l
4.0
3.8
—
5
37
(3012544) pH of Venous blood
16
136
1.19
0.21
4.5
3.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
13
0.00
0.21
0.0
2.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
15
127
1.20
0.20
3.3
2.1
ml/min/173m2
60.7
65.1
—
6
54
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
444.6
—
0
9
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
295.9
—
0
8
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
1.3
—
0
6
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
42.5
—
0
8
(3020564) Creatinine [Moles/volume] in Serum or Plasma
165
1625
1.17
0.19
34.6
15.6
umol/l
75.3
76.9
0.17
165
1625
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
58
1.22
0.18
3.0
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
108
1044
1.09
0.18
4.5
2.8
u/l
73.6
46.5
1.53
103
982
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
70
1.15
0.16
3.1
2.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
24
265
0.89
0.16
1.7
1.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
156
1580
0.91
0.12
28.4
15.1
mmol/l
3.9
4.0
0.96
151
1534
(3052851) Hemolysis interference index of Serum or Plasma
6
55
1.09
0.09
2.0
3.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
156
1574
0.94
0.07
27.7
15.0
mmol/l
139.4
139.8
1.16
151
1529
(3044889) 12 lead EKG panel
106
1071
0.98
0.03
5.4
3.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
14
132
1.07
0.02
1.4
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
12
113
1.07
0.02
4.4
2.7
kpa
4.5
4.4
0.11
12
106
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
13
137
0.94
0.01
1.6
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
17
163
1.05
0.01
3.1
1.9
—
—
—
0
0
(3002256) Pathology report gross observation
20
201
0.99
0.00
1.3
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
41
409
1.00
0.00
1.6
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
49
489
1.00
0.00
4.8
5.0
ug/l
3.3
2.9
0.09
44
438
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
42
425
0.98
0.00
1.6
1.6
mmol/l
1.8
1.3
1.82
35
358
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
20
195
1.03
0.00
8.0
6.1
—
—
—
0
0
(4010399)
12
115
1.05
0.00
2.1
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
19.0
—
939.4
—
0
8
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(44813793)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
115.6
—
0
5
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
21.3
—
1718.4
—
0
8
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
125.2
—
0
6
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
75
0.93
0.00
1.0
1.0
—
—
—
0
0
(4027681)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
112.0
—
0
7
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
58
0.86
0.00
3.4
3.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
9
0.00
0.00
0.0
2.4
—
4.2
—
0
9
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_DERMATOPOLYNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_DERMATOPOLYNAS | 2.848 [2.14, 3.79] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.207 |
During the follow-up period (1.1.1998 — 31.12.2019), 130 out of 495 females with M13_DERMATOPOLYNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_DERMATOPOLYNAS | 2.483 [1.74, 3.55] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.017 |
During the follow-up period (1.1.1998 — 31.12.2019), 87 out of 295 males with M13_DERMATOPOLYNAS died.
Mortality risk
Mortality risk for people of age
years, who have M13_DERMATOPOLYNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.296% | 0.595% |
| 5 | 1.603% | 3.498% |
| 10 | 4.077% | 7.608% |
| 15 | 7.333% | 14.038% |
| 20 | 12.719% | 22.408% |
Relationships between endpoints
↥Index endpoint: M13_DERMATOPOLYNAS – Dermatopolymyositis, unspecified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data